Singapore markets open in 6 hours 41 minutes
Straits Times Index
3,256.82 -12.45 (-0.38%) S&P 500
4,293.42 +13.27 (+0.31%) Dow
33,912.97 +151.92 (+0.45%) Nasdaq
13,102.40 +55.21 (+0.42%) BTC-USD
24,106.66 -150.32 (-0.62%) CMC Crypto 200
572.43 -18.34 (-3.10%)
Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:19PM EDT. Market open.
| Previous close | 104.80 |
| Open | 104.52 |
| Bid | 105.04 x 900 |
| Ask | 105.06 x 1000 |
| Day's range | 103.34 - 105.30 |
| 52-week range | 85.58 - 131.73 |
| Volume | |
| Avg. volume | 2,563,698 |
| Market cap | 65.199B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 45.14 |
| EPS (TTM) | 2.33 |
| Earnings date | 25 Oct 2022 - 31 Oct 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 116.68 |
- Zacks
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
- Motley Fool
Edwards Lifesciences (EW) Q2 2022 Earnings Call Transcript
With me on today's call are Mike Mussallem, chairman and chief executive officer; and Scott Ullem, chief financial officer. Also joining us for the Q&A portion of the call today will be Larry Wood, our global leader of TAVR; Bernard Zovighian, our global leader of TMTT; and Daveen Chopra, our global leader of Surgical Structural Heart.
- Zacks
Edwards Lifesciences (EW) Matches Q2 Earnings Estimates
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 1.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
